HDT Bio is a clinical stage private company developing advanced RNA vaccine products to treat and prevent infectious diseases and cancers. Leveraging its proprietary LION™ technology with unrivaled safety, potency, durability, and manufacturing advantages, HDT Bio’s self-replicating RNA (repRNA) vaccines harness the immune system to combat difficult-to-treat conditions and improve patient lives worldwide.